BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 17961071)

  • 1. Emerging roles of S-nitrosylation in protein misfolding and neurodegenerative diseases.
    Nakamura T; Lipton SA
    Antioxid Redox Signal; 2008 Jan; 10(1):87-101. PubMed ID: 17961071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory mediators leading to protein misfolding and uncompetitive/fast off-rate drug therapy for neurodegenerative disorders.
    Lipton SA; Gu Z; Nakamura T
    Int Rev Neurobiol; 2007; 82():1-27. PubMed ID: 17678953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell death: protein misfolding and neurodegenerative diseases.
    Nakamura T; Lipton SA
    Apoptosis; 2009 Apr; 14(4):455-68. PubMed ID: 19130231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Redox reactions induced by nitrosative stress mediate protein misfolding and mitochondrial dysfunction in neurodegenerative diseases.
    Gu Z; Nakamura T; Lipton SA
    Mol Neurobiol; 2010 Jun; 41(2-3):55-72. PubMed ID: 20333559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S-Nitrosylation and uncompetitive/fast off-rate (UFO) drug therapy in neurodegenerative disorders of protein misfolding.
    Nakamura T; Lipton SA
    Cell Death Differ; 2007 Jul; 14(7):1305-14. PubMed ID: 17431424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S-nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration.
    Uehara T; Nakamura T; Yao D; Shi ZQ; Gu Z; Ma Y; Masliah E; Nomura Y; Lipton SA
    Nature; 2006 May; 441(7092):513-7. PubMed ID: 16724068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms of nitrosative stress-mediated protein misfolding in neurodegenerative diseases.
    Nakamura T; Lipton SA
    Cell Mol Life Sci; 2007 Jul; 64(13):1609-20. PubMed ID: 17453143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S-nitrosylation of critical protein thiols mediates protein misfolding and mitochondrial dysfunction in neurodegenerative diseases.
    Nakamura T; Lipton SA
    Antioxid Redox Signal; 2011 Apr; 14(8):1479-92. PubMed ID: 20812868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of glutamatergic signaling to nitrosative stress-induced protein misfolding in normal brain aging and neurodegenerative diseases.
    Nakamura T; Gu Z; Lipton SA
    Aging Cell; 2007 Jun; 6(3):351-9. PubMed ID: 17388798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preventing Ca2+-mediated nitrosative stress in neurodegenerative diseases: possible pharmacological strategies.
    Nakamura T; Lipton SA
    Cell Calcium; 2010 Feb; 47(2):190-7. PubMed ID: 20060165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accumulation of misfolded protein through nitrosative stress linked to neurodegenerative disorders.
    Uehara T
    Antioxid Redox Signal; 2007 May; 9(5):597-601. PubMed ID: 17465882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Redox modulation by S-nitrosylation contributes to protein misfolding, mitochondrial dynamics, and neuronal synaptic damage in neurodegenerative diseases.
    Nakamura T; Lipton SA
    Cell Death Differ; 2011 Sep; 18(9):1478-86. PubMed ID: 21597461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rescue of ER oxidoreductase function through polyphenolic phytochemical intervention: implications for subcellular traffic and neurodegenerative disorders.
    Pal R; Cristan EA; Schnittker K; Narayan M
    Biochem Biophys Res Commun; 2010 Feb; 392(4):567-71. PubMed ID: 20097158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitrosative stress in the ER: a new role for S-nitrosylation in neurodegenerative diseases.
    Benhar M; Forrester MT; Stamler JS
    ACS Chem Biol; 2006 Jul; 1(6):355-8. PubMed ID: 17163772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein disulfide isomerase-immunopositive inclusions in patients with Alzheimer disease.
    Honjo Y; Ito H; Horibe T; Takahashi R; Kawakami K
    Brain Res; 2010 Aug; 1349():90-6. PubMed ID: 20550946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant protein S-nitrosylation contributes to the pathophysiology of neurodegenerative diseases.
    Nakamura T; Prikhodko OA; Pirie E; Nagar S; Akhtar MW; Oh CK; McKercher SR; Ambasudhan R; Okamoto S; Lipton SA
    Neurobiol Dis; 2015 Dec; 84():99-108. PubMed ID: 25796565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase Separation and Cytotoxicity of Tau are Modulated by Protein Disulfide Isomerase and S-nitrosylation of this Molecular Chaperone.
    Wang K; Liu JQ; Zhong T; Liu XL; Zeng Y; Qiao X; Xie T; Chen Y; Gao YY; Tang B; Li J; Zhou J; Pang DW; Chen J; Chen C; Liang Y
    J Mol Biol; 2020 Mar; 432(7):2141-2163. PubMed ID: 32087196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The thioredoxin superfamily in oxidative protein folding.
    Lu J; Holmgren A
    Antioxid Redox Signal; 2014 Jul; 21(3):457-70. PubMed ID: 24483600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ellagic acid mitigates SNO-PDI induced aggregation of Parkinsonian biomarkers.
    Kabiraj P; Marin JE; Varela-Ramirez A; Zubia E; Narayan M
    ACS Chem Neurosci; 2014 Dec; 5(12):1209-20. PubMed ID: 25247703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein S-Nitrosylation as a Therapeutic Target for Neurodegenerative Diseases.
    Nakamura T; Lipton SA
    Trends Pharmacol Sci; 2016 Jan; 37(1):73-84. PubMed ID: 26707925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.